BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2519932)

  • 1. Modulation of cancer patients' immune responses by anti-idiotypic antibodies.
    Herlyn D; Wettendorff M; Koprowski H
    Int Rev Immunol; 1989; 4(4):347-57. PubMed ID: 2519932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
    Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
    J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype.
    Wettendorff M; Iliopoulos D; Schmoll E; Koprowski H; Herlyn D
    J Immunol Methods; 1989 Jan; 116(1):105-15. PubMed ID: 2783712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotype immunization of cancer patients: modulation of the immune response.
    Herlyn D; Wettendorff M; Schmoll E; Iliopoulos D; Schedel I; Dreikhausen U; Raab R; Ross AH; Jaksche H; Scriba M
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8055-9. PubMed ID: 3500471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
    Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
    Cancer Immunol Immunother; 1994 Mar; 38(3):149-59. PubMed ID: 8124683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D; Ross AH; Iliopoulos D; Koprowski H
    Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.
    Wettendorff M; Iliopoulos D; Tempero M; Kay D; DeFreitas E; Koprowski H; Herlyn D
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3787-91. PubMed ID: 2786203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
    Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
    J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?
    Frödin JE; Faxas ME; Hagström B; Lefvert AK; Masucci G; Nilsson B; Steinitz M; Unger P; Mellstedt H
    Hybridoma; 1991 Aug; 10(4):421-31. PubMed ID: 1937495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?
    Fagerberg J; Frödin JE; Wigzell H; Mellstedt H
    Cancer Immunol Immunother; 1993 Sep; 37(4):264-70. PubMed ID: 8348565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
    Comacchio RM; Bradley J; Hohmann AW
    Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733.
    Maruyama H; Benden A; Li W; Zaloudik J; Koido T; Taupin JL; Acres B; Somasundaram R; Prewett M; Herlyn D
    Int J Cancer; 1996 Feb; 65(4):547-53. PubMed ID: 8621241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
    Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
    Irvine K; Schlom J
    Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
    Fagerberg J; Hjelm AL; Ragnhammar P; Frödin JE; Wigzell H; Mellstedt H
    Cancer Res; 1995 May; 55(9):1824-7. PubMed ID: 7728746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-idiotypic antibodies bear the internal image of a human tumor antigen.
    Herlyn D; Ross AH; Koprowski H
    Science; 1986 Apr; 232(4746):100-2. PubMed ID: 3952496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
    Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
    Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.
    Bhattacharya-Chatterjee M; Mukerjee S; Biddle W; Foon KA; Köhler H
    J Immunol; 1990 Oct; 145(8):2758-65. PubMed ID: 1698862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
    Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3).
    Bhattacharya-Chatterjee M; Chatterjee SK; Vasile S; Seon BK; Kohler H
    J Immunol; 1988 Aug; 141(4):1398-403. PubMed ID: 2899603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.